EMAIL THIS PAGE TO A FRIEND

Journal of the American College of Cardiology

Potent P2Y


PMID 28335837

Abstract

Sex-specific differences in response to antiplatelet therapies have been described. Whether women and men derive comparable benefit from intensification of antiplatelet therapy remains uncertain. The study investigated the efficacy and safety of the potent P2Y A collaborative sex-specific meta-analysis was conducted of phase III or IV randomized trials of potent P2Y Potent P2Y In randomized trials, the efficacy and safety of the potent P2Y